ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,381Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 45

$1.18M Total Retail Price of All Prescriptions

Rank: 4 out of 45

813 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 813 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 813 patients filled at least one prescription for a schedule three drug, compared to an average of 25%.

Risky Drugs to Seniors

3% of this provider’s 18,726 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 1,093 932 1 2
OMEPRAZOLE 771 670 2 3
METOPROLOL SUCCINATE 654 569 3 18
AMLODIPINE BESYLATE 648 579 4 7
LEVOTHYROXINE SODIUM 555 471 5 5
HYDROCODONE-ACETAMINOPHEN 521 466 S3 6 1
FUROSEMIDE 512 470 7 6
CITALOPRAM HBR 467 377 8 21
PRAVASTATIN SODIUM 462 355 9 14
GABAPENTIN 458 390 10 9
SIMVASTATIN 454 374 11 4
METFORMIN HCL ER 446 372 12 48
TRIAMTERENE-HCTZ 370 297 13 46
METOPROLOL TARTRATE 361 282 14 10
POTASSIUM CHLORIDE 344 301 15 13
WARFARIN SODIUM 317 273 16 17
ATORVASTATIN CALCIUM 300 270 17 12
METHYLPREDNISOLONE 288 244 18 86
NEXIUM 261 179 19 19
DICLOFENAC SODIUM 258 225 20 80
ZOLPIDEM TARTRATE 256 195 21 22
LOSARTAN POTASSIUM 216 202 22 27
FLUTICASONE PROPIONATE 213 167 23 44
CEFDINIR 210 182 24 154
AZITHROMYCIN 207 189 25 39
AMITRIPTYLINE HCL 201 143 R 26 42
ATENOLOL 201 165 26 15
CLOPIDOGREL 198 163 28 26
DONEPEZIL HCL 193 182 29 37
DIGOXIN 180 179 30 78
ALENDRONATE SODIUM 176 173 31 62
TAMSULOSIN HCL 172 167 32 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 169 140 33 29
GLIMEPIRIDE 160 144 34 72
RAMIPRIL 157 141 35 113
CRESTOR 154 131 36 23
ALLOPURINOL 145 106 37 36
VENLAFAXINE HCL ER 143 114 38 93
HYDROCHLOROTHIAZIDE 135 114 39 11
DIOVAN 133 123 40 43
SULFAMETHOXAZOLE-TRIMETHOPRIM 131 101 41 92
VYTORIN 129 91 42 139
PANTOPRAZOLE SODIUM 126 95 43 31
PLAVIX 125 107 44 35
MELOXICAM 123 96 45 28
CIPROFLOXACIN HCL 121 106 46 85
CLONIDINE HCL 121 120 46 61
RANITIDINE HCL 116 70 48 16
MECLIZINE HCL 115 111 49 73
GLYBURIDE 111 92 R 50 55
AMOXICILLIN 107 96 51 63
NAMENDA 106 106 52 57
ESCITALOPRAM OXALATE 106 79 52 120
BUSPIRONE HCL 103 69 54 73
TRAMADOL HCL 102 77 55 20
DOXYCYCLINE HYCLATE 98 73 56 104
CYCLOBENZAPRINE HCL 96 36 R 57 45
LANTUS 96 77 57 60
CARVEDILOL 91 84 59 25
METFORMIN HCL 88 75 60 8
SYNTHROID 87 67 61 125
PROAIR HFA 86 50 62 38
FINASTERIDE 85 81 63 142
TIZANIDINE HCL 81 70 64 41
ADVAIR DISKUS 79 62 65 70
QUETIAPINE FUMARATE 78 61 66 101
WELCHOL 77 69 67 178
CELEBREX 75 66 68 110
BISOPROLOL-HYDROCHLOROTHIAZIDE 74 62 69 217
LYRICA 73 57 70 99
JANUVIA 72 69 71 91
LANSOPRAZOLE 72 50 71 98
DIOVAN HCT 72 43 71 122
POLYETHYLENE GLYCOL 3350 70 68 74 53
ENALAPRIL MALEATE 70 69 74 69
DOXEPIN HCL 69 65 76 123
CYMBALTA 68 36 77 59
LABETALOL HCL 68 66 77 228
DILTIAZEM ER 67 61 79 116
FLUOXETINE HCL 67 56 79 47
GLIPIZIDE 65 65 81 56
ZETIA 64 52 82 50
PAROXETINE HCL 63 41 83 51
TERAZOSIN HCL 62 62 84 237
EVISTA 62 62 84 152
ACYCLOVIR 59 47 86 162
LOSARTAN-HYDROCHLOROTHIAZIDE 58 58 87 96
FOSINOPRIL SODIUM 57 47 88 146
INSULIN SYRINGE 54 36 89 84
IBUPROFEN 54 30 89 40
ACTOS 54 54 89 115
SPIRONOLACTONE 51 51 92 87
TRIAMTERENE-HYDROCHLOROTHIAZID 51 50 92 166
PROPRANOLOL HCL 50 43 94 135
IRBESARTAN 50 45 94 257
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.